41st Annual J.P. Morgan Healthcare Conference
Holland & Knight Members in Attendance
Maria T. Currier is a co-leader of the firm's Healthcare & Life Sciences Industry Team. She also is a partner and co-chair of Holland & Knight's National Healthcare Practice. She has more than 34 years of experience serving clients in the healthcare industry and is Board Certified in Health Law as recognized by The Florida Bar Board of Legal Specialization and Education. Her healthcare practice focuses on health reform matters, mergers and acquisitions, joint ventures, commercial transactions, healthcare regulatory matters, fraud and abuse, managed care and international business ventures for healthcare clients.
Click here to view full bio »
Jeffrey W. Mittleman is a co-leader of the firm's Healthcare & Life Sciences Industry Group and a partner in the Business Section of Holland & Knight. He is also a member of the Compliance Services Team. He practices in the areas of health, regulatory and corporate law.
Click here to view full bio »
Michael Werner is a co-leader of Holland & Knight's Healthcare & Life Sciences Team and a Washington, D.C., public policy and regulatory attorney. Mr. Werner has almost three decades of healthcare law, lobbying, regulatory and reimbursement experience in Washington. He focuses on issues affecting FDA-regulated entities, including biotechnology and pharmaceutical companies developing and manufacturing prescription and over-the-counter (OTC) drugs, biosimilars, cosmetics, dietary supplements and digital-health technologies. His specific areas of knowledge include FDA regulations regarding product approval, marketing and distribution, and Medicare, Medicaid and commercial insurance reimbursement.
Click here to view full bio »
Miranda Franco is a senior policy advisor in Holland & Knight's Washington, D.C., office and a member of the firm's Public Policy & Regulation Group. She has nearly two decades of collective experience in health policy and government relations, representing advocacy positions to policymakers, national physician specialty societies, state medical societies, hospitals and other healthcare organizations.
Click here to view full bio »
Paul J. Jaskot is a corporate services attorney in Holland & Knight's Philadelphia office, where he focuses on mergers and acquisitions, securities, corporate governance, general corporate and financing matters. He counsels a wide range of clients, from early-stage companies to well-established, publicly traded enterprises, to professional services firms.
Click here to view full bio »
Sara M. Klock is a Washington, D.C., attorney and a member of Holland & Knight's Public Policy & Regulation Group. Ms. Klock focuses her practice on food, agriculture, drug and device, digital health and life sciences.
Click here to view full bio »
Deryk A. Loiacono is a Miami business attorney whose practice focuses on mergers and acquisitions, private equity, joint ventures and other general corporate matters. During law school, Mr. Loiacono served on the executive board of the Journal of Technology Law & Policy.
Click here to view full bio »
Andrew I. Namkung is an attorney in Holland & Knight's Boston office and a member of the firm's Healthcare & Life Sciences Team. His practice comprises of three broad categories, all within the healthcare and life sciences industry: regulatory advising, investigations and enforcement actions, and healthcare transactions.
Ashley L. Shively is a privacy attorney and class action litigator in Holland & Knight's San Francisco office. Ms. Shively counsels public and private companies on consumer protection and data privacy issues with respect to product development, sign-up and point-of-sale procedures, digital marketing, regulatory compliance, incident response, and state and federal enforcement. She regularly advises on the Children's Online Privacy Protection Act (COPPA), Controlling the Assault of Non-Solicited Pornography and Marketing (CAN-SPAM) Act of 2003, Fair Credit Reporting Act (FCRA), Gramm-Leach-Bliley Act (GLBA), state privacy and unfair and deceptive practices laws, and similar legal and regulatory requirements.
Click here to view full bio »
Jordan B. Taylor focuses his practice on mergers and acquisitions, private equity, joint ventures and other general corporate matters. In addition, Mr. Taylor represents both insureds and underwriters in connection with transactional risk products, including the issuance of representations and warranties insurance policies. Prior to becoming a lawyer, he obtained his Master's degree in accounting from the University of Florida Fisher School of Accounting.
Click here to view full bio »
Charles A. Weiss is a partner in Holland & Knight's New York office and head of the New York Intellectual Property Group. Combining accomplished trial lawyer with seasoned transactional counselor, Mr. Weiss concentrates his practice on technology-driven litigation and transactions, primarily in pharmaceutical, biotechnology and adjacent fields. He also counsels clients on questions of patent validity and infringement, provides a litigator's perspective on prosecution matters, and assists with regulatory and compliance matters.
Click here to view full bio »
Melissa A. Wong is an attorney in Holland & Knight's Boston office and is a member of the firm's national Healthcare & Life Sciences Industry Group, with a focus on managed care and federal healthcare programs, including Medicare and Medicaid, as well as prescription drug coverage and reimbursement issues.
Click here to view full bio »